港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

罗欣药业

16.960

-0.020-0.12%

成交量：72.00万

成交额：1,220.91万

市值：103.39亿

市盈率：24.11

高：16.980

开：16.940

低：16.940

收：16.980

52周最高：16.980

52周最低：10.000

股本：6.10亿

香港流通股本：1.65亿

量比：- -

换手率：0.44%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

市销率: - -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

罗欣药业：截止至2026年1月30日，公司股东总户数为37,496

罗欣药业2025年业绩预告释放了哪些信号？

罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险

股市必读：罗欣药业(002793)股东户数3.83万户，较上期减少0.94%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/08058"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"08058","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"08058\",,,,,undefined,":{"symbol":"08058","market":"HK","secType":"STK","nameCN":"罗欣药业","latestPrice":16.96,"timestamp":1496649585126,"preClose":16.98,"halted":4,"volume":720000,"delay":0,"changeRate":-0.001177856301531188,"floatShares":164560000,"shares":609600000,"eps":0.7034382563557334,"marketStatus":"退市","change":-0.02,"latestTime":"06-05 15:59:45","open":16.94,"high":16.98,"low":16.94,"amount":12209120,"amplitude":0.002356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":5,"adr":0,"exchange":"SEHK","adjPreClose":16.98,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"08058\",,,,,undefined,":{"symbol":"08058","floatShares":164560000,"roa":"--","roe":"--","lyrEps":0,"shares":609600000,"dividePrice":0,"high":16.98,"amplitude":0.002356,"preClose":16.98,"low":16.94,"week52Low":10,"pbRate":"--","week52High":16.98,"institutionHeld":0,"latestPrice":16.96,"eps":0.7034382563557334,"divideRate":0,"volume":720000,"delay":0,"ttmEps":0,"open":16.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/08058\",params:#limit:5,,,undefined,":[{"date":"2017-06-16","symbol":"08058","reason":"有条件要约","type":"delisting","dateTimestamp":1497542400000},{"market":"HK","date":"2017-05-12","symbol":"08058","name":"罗欣药业","time":"","type":"earning","dateTimestamp":1494518400000,"reportTimeType":""}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"08058\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"08058\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"08058\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608859755","title":"罗欣药业：截止至2026年1月30日，公司股东总户数为37,496","url":"https://stock-news.laohu8.com/highlight/detail?id=2608859755","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608859755?lang=zh_cn&edition=fundamental","pubTime":"2026-02-02 16:33","pubTimestamp":1770021190,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止1月30日已收盘公司股东人数是多少？谢谢！罗欣药业回复：尊敬的投资者，您好！截止至2026年1月30日，公司股东总户数为37,496。感谢您的关注！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260202/31992440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0201","08058","BK0132","BK0001","002793"],"gpt_icon":0},{"id":"2607109049","title":"罗欣药业2025年业绩预告释放了哪些信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607109049","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607109049?lang=zh_cn&edition=fundamental","pubTime":"2026-01-30 22:07","pubTimestamp":1769782025,"startTime":"0","endTime":"0","summary":"1月30日，罗欣药业发布2025年业绩预告。报告期内，公司预计2025年度归属于母公司所有者的净利润将出现亏损，区间为万元至万元。与上年同期(万元)相比，亏损额预计大幅减少万元至万元，同比减亏幅度达%至%。　　报告同时显示，罗欣药业2025年净利润大幅减亏的原因是其核心创新药产品替戈拉生片快速增长的拉动和产品结构和增长质量持续提升。　　今天我们就借机来分析一下，罗欣药业这家老牌公司，当下及未来有哪些看点？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260130/31988133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0132","BK0201","BK0001","08058","002793","BK0239"],"gpt_icon":0},{"id":"2603969552","title":"罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969552","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603969552?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 17:09","pubTimestamp":1768554540,"startTime":"0","endTime":"0","summary":"近日，罗欣药业（维权）一则转让控股子公司的公告引发市场关注。公司将以6250万元的价格将旗下乐康制药100%股权转让给成立仅两年、注册资本仅20万元的君康生物。而截至2025年9月30日，乐康制药净资产为7323.83万元，交易价明显低于净资产。　　这笔“低价出售”背后，不仅暴露出标的公司持续亏损、资产萎缩的经营困境，也折射出罗欣药业近年来为扭亏频频剥离资产、债务压力渐显的复杂局面。　　乐康制药并非罗欣药业近期出售的唯一资产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-16/doc-inhhnzav3923248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0001","08058","BK0201","BK0132","002793","BK0239"],"gpt_icon":0},{"id":"2603522779","title":"股市必读：罗欣药业(002793)股东户数3.83万户，较上期减少0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603522779","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603522779?lang=zh_cn&edition=fundamental","pubTime":"2026-01-13 08:00","pubTimestamp":1768262439,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年1月9日，罗欣药业股东户数为3.83万户，较前期减少365户，户均持股升至2.84万股。资金流向1月12日主力资金净流出1174.94万元；游资资金净流入310.47万元；散户资金净流入864.47万元。股东户数变动近日罗欣药业披露，截至2026年1月9日公司股东户数为3.83万户，较12月31日减少365.0户，减幅为0.94%。户均持股数量由上期的2.81万股增加至2.84万股，户均持股市值为14.29万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260113/31936006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["08058","BK0132","BK0239","002793","BK0001","BK0201"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/08058\",params:#limit:6,delay:false,,,undefined,":[]}}